• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Babson Diagnostics’ BetterWay Achieves Regulatory Milestone

    WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study

    Everly Health Releases At-Home Collection Kidney Health Test

    Kenco Adds Two to its Life Sciences Division Team

    FDA Grants Breakthrough Device Status to Brain-Computer Interface
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    A Peek Into the 2028 MPO Summit

    Retail Healthcare Disruptors and Medical Devices

    Six Developments Your Talent Strategy Should Prepare for in 2024

    The Power and Paradox of Never

    Navigating the Q-Sub Program: How Experienced Lab Partners Can Help Streamline Regulatory Submission
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Johari Digital Healthcare Ltd.

    Cirtec Medical

    Arthur G Russell Company, The

    BMP Medical

    Qosina Corp.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Telemedicine for Neurology: 5 Benefits of Remote Management

    Machining 101: A Review of Machining Components with a Five-Axis System

    MedTech 2024: Top 5 Trends Shaping a Dynamic Industry

    Early Warning: A Q&A with Abbott's CMO of Heart Failure

    2023 in Review: Medtech's Mega-M&A Is MIA
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Johari Digital Healthcare Ltd.

    Cirtec Medical

    Arthur G Russell Company, The

    BMP Medical

    Qosina Corp.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Integrating Point of Care to Future Proof our Community Health System

    Ensuring diagnostic equity—not just in hospitals, but also pharmacies, schools and more.

    Integrating Point of Care to Future Proof our Community Health System
    The LumiraDx platform. Image courtesy of LumiraDx.
    Dr. Brian DuChateau, VP US Clinical and Scientific Affairs, LumiraDx09.16.22
    We live in an increasingly impatient world where our need for immediate results has trickled into all aspects of our lives, including our health care expectations.
     
    At least one fortunate by-product of the pandemic has been the rapid implementation and adoption of innovative technologies which fulfil those expectations for us today. These instant health care delivery tools, including point of care antigen tests have transformed the way we deliver health care at the point of need, especially in community-based settings. These paramount tools allow speed and accuracy at the nexus of action or the point of need where critical split-second medical decisions are made.
     
    While rapid diagnostics provide an effective care delivery model at the point of need, they are also crucial for controlling infectious outbreaks. Bill Gates, in his recent book, “How to Prevent the Next Pandemic” presents a detailed strategy on what can be done at a global scale to avoid the catastrophic impact of another pandemic. His recommended framework for pandemic prevention and response coordination specifically calls out point of care diagnostics as having untapped potential, which we can apply to disease outbreaks.
     
    If we are to future proof our health system today, we must ensure diagnostic equity—integrating point of care diagnostics into every part of our health system—not just hospitals, but also pharmacies, schools, and other community settings.
     
    Laboratory-run PCR tests are expensive, require skilled labor to perform and do not guarantee this level of efficiency, especially for care centers in remote communities. Laboratory tests may take days to run, and the facilities are often miles away from community hospitals, not an enabling ecosystem for treatment follow through for people that travel long distances.
     
    Additionally, rapid antigen tests also circumvent the “persistent positive” results common to PCR tests, which indicate an infection for an extended period even when the person is likely no longer contagious. Antigen tests offer an advantageous alternative, since a growing body of evidence demonstrate that antigen tests correlate more closely to culture suggesting they only detect active infections. This level of certainty empowers our ability to go back to “normal.”
     
    The power of next generation point of care diagnostics was discussed at the recent American Association for Clinical Chemistry (AACC) Annual Conference in Chicago this summer. The discussion presented data-backed insights on the impact of LumiraDx advanced microfluidic technology over lateral flow point-of-care antigen tests, and the role of these rapid immunoassays in response to the COVID-19 pandemic.
     
    LumiraDx, established in 2014, is transforming community-based healthcare by providing fast, accurate, and comprehensive diagnostic information to healthcare providers at the point of need, thereby enabling better medical decisions and improved patient outcomes at a much lower cost.
     
    As the Scientific & Clinical Affairs Vice President at LumiraDx, I spoke alongside Dr. Paul Drain, associate professor at the University of Washington in the Departments of Global Health, Medicine (Infectious Diseases), and Epidemiology at the session. Dr. Drain presented his prospective validation study of the LumiraDx severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapid antigen test, which uses a high-sensitivity, microfluidic immunoassay to detect the nucleocapsid protein of SARS-CoV-2 for diagnosing acute coronavirus disease 2019 (COVID-19) in adults and children across point of care settings.
     
    The study showed that, among 512 participants, the LumiraDx SARS-CoV-2 Ag has a 97.6% positive agreement to RT PCR in patients up to 12 days following symptom onset, and 100% PPA up to Ct 33. These findings testify to the effectiveness of rapid, high-sensitivity assay using nasopharyngeal or anterior nasal sampling, offering significant improvements for diagnosing acute SARS-CoV-2 infection in clinic- and community-based settings. Dr. Drain also shared more recent data showing that differences between Delta and Omicron variants did not affect the performance of the LumiraDx SARS-CoV-2 Antigen Test.
     
    As we look ahead, immediacy is central to meeting patient care needs and optimizing provider decision making. Given the looming challenges of future pandemics, we should support policies that invest in integrated, scalable diagnostic solutions, which we can deploy rapidly at the point of care, especially in communities where little healthcare infrastructure is present. This will enable effective decision-making at the point of need, save health care costs, and improve patient outcomes.
     

    Brian K. DuChateau, Ph.D., D (ABMLI) is a board-certified clinical laboratory immunologist. He received his Ph.D. in immunology and medical microbiology from the University of Wisconsin and completed a post-doctoral residency at the Chicago Medical School. DuChateau has over 20 years of experience as a clinical laboratory director and 12 years of in vitro diagnostics experience. He has served as a Clinical Laboratory Director at PathLab, LabCorp, BloodCenter of WI, and ConVerge diagnostic services. He has held leadership positions at Dako and The Binding Site. He currently serves as the Vice President of Scientific and Clinical Affairs at LumiraDx.
    Related Searches
    • Diagnostics
    Related Knowledge Center
    • Diagnostics
      Loading, Please Wait..

      Breaking News
      • Babson Diagnostics’ BetterWay Achieves Regulatory Milestone
      • WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study
      • Everly Health Releases At-Home Collection Kidney Health Test
      • Kenco Adds Two to its Life Sciences Division Team
      • FDA Grants Breakthrough Device Status to Brain-Computer Interface
      View Breaking News >
      CURRENT ISSUE

      November 2023

      • MPO's 2023 Medical Device Industry Year in Review
      • The Beat Goes On in the Cardiovascular Device Market
      • Medical Manufacturers Gain Support from 3D Printing
      • The Intelligent Tools Medical Device Manufacturers Already Own
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Women in Nutraceuticals Hires Executive Director Rebecca Takemoto
      FDA Issues Interim Response to Nammex’s Mushroom Labeling Petition
      MSM Linked to Improvements in Knee Pain
      Coatings World

      Latest Breaking News From Coatings World

      Orion S.A. Has Four Carbon Black Plants Awarded ISCC PLUS
      Peninsula Polymers Acquires New Distribution Center in Indiana
      PPG Completes COLORFUL COMMUNITIES Project in Shildon, UK
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Babson Diagnostics’ BetterWay Achieves Regulatory Milestone
      WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study
      Everly Health Releases At-Home Collection Kidney Health Test
      Contract Pharma

      Latest Breaking News From Contract Pharma

      FDA Approves Bio-Thera's Biosimilar Referencing Roche’s Avastin
      Full-Life Technologies to Build GMP Radiopharmaceuticals Mfg. Facility
      Innovent Biologics, Synaffix Expand ADC Licensing Deal
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      COSRX’s Latest TikTok Campaign Accumulates 3.2B Views on TikTok
      Christian Louboutin Taps Morgane Martini as Global Makeup Artist
      Shiseido Forms New Venture Fund
      Happi

      Latest Breaking News From Happi

      Estée Lauder Lead Scientist Dr. Nadine Pernodet To Lecture At SCC Science Meeting
      Topical Testosterone Formulation for Chest Hair Growth
      New York City Is Hub for Cosmetic Chemistry Next Week
      Ink World

      Latest Breaking News From Ink World

      Orion S.A. Now Has Four Carbon Black Plants Awarded ISCC PLUS
      BASF Commits to Scope 3.1 Emissions Targets
      Dantex and ACTEGA Partner on ECOLEAF
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Analyzing the Russian label market, Carter boosts brands and more
      FLAG’s December Lunch & Learn to feature Omet
      UPM Raflatac releases neuromarketing study findings
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Ginni Strikes Deal to Sell Spinning, Knitting Operations
      Campen Machinery Announces Patent Pending Status for Airlaid Trays
      Veocel Partners with Beauty and Feminine Care Brands in Asia Pacific
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Fujitsu, iSurgery Launch Bone Health Promotion Project in Japan
      Wenzel Spine Hires Dr. Robert Gordon as Executive Chairman
      Dr. Srikant Datar to Retire from Stryker's Board of Directors
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Intel CEO Pat Gelsinger to Cover AI During CES 2024 Keynote
      Ciena Invests in US Manufacturing with Flex
      Sitoo, SML Team Up to Enhance CX and Retail Operations

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login